Finance

Lists
ELDN:NASDAQ
Eledon Pharmaceuticals Inc
၂.၆၈ US$
-၁.၄၇%
(-၀.၀၄၀) 1D
၂.၇၂ US$
+၁.၄၃% (+၀.၀၃၈)
After hours
Closed: စက် ၂၄, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELDN...
Open
၂.၇၂ US$
High
၂.၇၇ US$
Low
၂.၆၀ US$
Mkt. cap
၂၁.၇၈ ကုဋေ
Avg. vol.
၉.၆၂ သိန်း
Volume
၁.၀၃ သန်း
52-wk high
၄.၆၀ US$
52-wk low
၁.၃၆ US$
EPS
-၀.၉၆ US$
Beta
၀.၉၃
Shares outstanding
၈.၁၃ ကုဋေ
No. of employees
၃၃
Open
၂.၇၂ US$
High
၂.၇၇ US$
Low
၂.၆၀ US$
Mkt. cap
၂၁.၇၈ ကုဋေ
Avg. vol.
၉.၆၂ သိန်း
Volume
၁.၀၃ သန်း
52-wk high
၄.၆၀ US$
52-wk low
၁.၃၆ US$
EPS
-၀.၉၆ US$
Beta
၀.၉၃
Shares outstanding
၈.၁၃ ကုဋေ
No. of employees
၃၃
News stories
From web sources and news partners
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၂ ရက်
Eledon Pharmaceuticals (ELDN) Shares Rise on Positive Tegoprubar
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၂ ရက်
Eledon’s tegoprubart shows kidney function advantage in phase 2 trial
About Eledon Pharmaceuticals Inc
CEO-
Employees၃၃
Founded၂၀၀၄
Headquartersအိုင်ရာဗင်န်, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteeledon.com
Analyst ratings
Based on 4 analysts giving stock ratings to ELDN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ELDN in the last 3 months.
Highest
Current ၂.၆၈ US$
၁၂.၀၀ US$ (+၃၄၇.၇၆%)
Average
၉.၅၀ US$ (+၂၅၄.၄၈%)
Lowest
၈.၀၀ US$ (+၁၉၈.၅၁%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
၁၀.၀၀ US$
+၂၇၃.၁%
09/23/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
၈.၀၀ US$
+၁၉၈.၅%
09/22/2026
Unknown Analyst
Guggenheim
Buy
Maintained
၈.၀၀ US$
+၁၉၈.၅%
08/13/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
၁၂.၀၀ US$
+၃၄၇.၈%
07/21/2026
Vamil Divan
Guggenheim
Buy
Maintained
၈.၀၀ US$
+၁၉၈.၅%
03/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၅၀ ကုဋေ
၁.၇၅ ကုဋေ
၁.၇၂ ကုဋေ
၁.၈၂ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၁၀ သန်း
၃.၉၉ သန်း
၃.၉၈ သန်း
၄.၆၄ သန်း
Operating expense
၁.၉၁ ကုဋေ
၂.၁၅ ကုဋေ
၂.၁၂ ကုဋေ
၂.၂၉ ကုဋေ
Total operating expenses
၁.၉၁ ကုဋေ
၂.၁၅ ကုဋေ
၂.၁၂ ကုဋေ
၂.၂၉ ကုဋေ
Operating income
-၁.၉၁ ကုဋေ
-၂.၁၅ ကုဋေ
-၂.၁၂ ကုဋေ
-၂.၂၉ ကုဋေ
Other non operating income
၁.၆၁ သန်း
၁.၁၁ ကုဋေ
-၁.၇၈ ကုဋေ
-၈.၇၆ သန်း
EBT including unusual items
-၁.၇၅ ကုဋေ
-၁.၀၄ ကုဋေ
-၃.၉၀ ကုဋေ
-၃.၁၆ ကုဋေ
EBT excluding unusual items
-၁.၇၅ ကုဋေ
-၁.၀၄ ကုဋေ
-၃.၉၀ ကုဋေ
-၃.၁၆ ကုဋေ
Income tax expense
-
၃.၅၀ သောင်း
-
-
Effective tax rate
-
-၀.၃၄%
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၇၅ ကုဋေ
-၁.၀၄ ကုဋေ
-၃.၉၀ ကုဋေ
-၃.၁၆ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၂၁
-၀.၁၀
-၀.၃၃
-၀.၂၇
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ